Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia

JAMA

Volumn 293, Issue 22, 2005, Pages 2726-2731

  Drobniewski, Francis ^a,d   Balabanova, Yanina ^a,b   Nikolayevsky, Vladyslav ^a   Ruddy, Micheal ^a   Kuznetzov, Sergey ^c   Zakharova, Svetlana ^b   Melentyev, Alexander ^b   Fedorin, Ivan ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Samara TB Service   (Russian Federation)

^c N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADULT; ALCOHOL CONSUMPTION; ANALYTIC METHOD; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; CIGARETTE SMOKING; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE LOCUS; HEPATITIS B; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PRISONER; RISK ASSESSMENT; RISK FACTOR; RUSSIAN FEDERATION; SEXUAL BEHAVIOR; SOCIAL ASPECT; SPOLIGOTYPING; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; THORAX RADIOGRAPHY; CLASSIFICATION; CROSS-SECTIONAL STUDY; GENETICS; MICROBIOLOGY; PATHOGENICITY; PRISON; TUBERCULOSIS; VIRULENCE;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MYCOBACTERIUM TUBERCULOSIS; PRISONS; RISK FACTORS; RUSSIA; TUBERCULOSIS, MULTIDRUG-RESISTANT; VIRULENCE;

EID: 20144381280     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.293.22.2726     Document Type: Article

References (26)

1. Drobniewski F, Balabanova Y, Coker R. Clinical features, diagnosis, and management of multiple drug-resistant tuberculosis since 2002. Curr Opin Pulm Med. 2004;10:211-217.
2. Van Soolingen D. Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements. J Intern Med. 2001;249:1-26.
3. Glynn JR, Whiteley J, Bifani PJ, Kremer K, van Soolingen D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis. 2002;8:843-849.
4. Bifani PJ, Mathema B, Kurepina NE, Kreiswirth BN. Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends Microbiol. 2002;10:45-52.
5. Van Soolingen D, Qian L, de Haas PE, et al. Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J Clin Microbiol. 1995;33:3234-3238.
6. Kruuner A, Hoffner SE, Sillastu H, et al. Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol. 2001;39:3339-3345.
7. Narvskaia OV, Vishnevskii BI, El'kin AV, et al. Molecular genetic characteristics of Mycobacterium tuberculosis isolated from patients operated on for pulmonary tuberculosis. Probl Tuberk. 2002;3:50-53.
8. Narvskaya O, Otten T, Limeschenko E, et al. Nosocomial outbreak of multidrug-resistant tuberculosis caused by a strain of Mycobacterium tuberculosis W-Beijing family in St. Petersburg, Russia. Eur J Clin Microbiol Infect Dis. 2002;21:596-602.
9. Tracevska T, Jansone I, Baumanis V, Marga O, Lillebaek T. Prevalence of Beijing genotype in Latvian multidrug-resistant Mycobacterium tuberculosis isolates. Int J Tuberc Lung Dis. 2003;7:1097-1103.
10. Van Soolingen D, Arbeit RD. Dealing with variation in molecular typing of Mycobacterium tuberculosis: low-intensity bands and other challenges. J Med Microbiol. 2001;50:749-751.
11. Kruuner A, Pehme L, Ghebremichael S, Koivula T, Hoffner SE, Mikelsaar M. Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis. Clin Infect Dis. 2002;35:146-155.
12. Anh DD, Borgdorff MW, Van LN, et al. Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerg Infect Dis. 2000;6:302-305.
13. Pfyffer GE, Strassle A, van Gorkum T, et al. Multidrug-resistant tuberculosis in prison inmates, Azerbaijan. Emerg Infect Dis. 2001;7:855-861.
14. Lan NT, Lien HT, Tung le B, Borgdorff MW, Kremer K, van Soolingen D. Mycobacterium tuberculosis Beijing genotype and risk for treatment failure and relapse, Vietnam. Emerg Infect Dis. 2003;9:1633-1635.
15. Lillebaek T, Andersen AB, Dirksen A, Glynn JR, Kremer K. Mycobacterium tuberculosis Beijing genotype. Emerg Infect Dis. 2003;9:1553-1557.
16. Kimerling ME, Slavuckij A, Chavers S, et al. The risk of MDR-TB and polyresistant tuberculosis among the civilian population of Tomsk city, Siberia, 1999. Int J Tuberc Lung Dis. 2003;7:866-872.
17. Toungoussova S, Caugant DA, Sandven P, Mariandyshev AO, Bjune G. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia. Int J Tuberc Lung Dis. 2002;6:406-414.
18. Coker R, Dimitrova B, Drobniewski F, et al. Tuberculosis control in Samara Oblast, Russia: institutional and regulatory environment. Int J Tuberc Lung Dis. 2003;7:920-932.
19. Van Soolingen D, Hermans PW. Epidemiology of tuberculosis by DNA fingerprinting. Eur Respir J Suppl. 1995;20:649s-656s.
20. Supply P, Lesjean S, Savine E, Kremer K, van Soolingen D, Locht C. Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units. J Clin Microbiol. 2001;39:3563-3571.
21. Abramson JH, Gahlinger PM. Computer Programs for Epidemiologists PEPI v 4.0. Salt Lake City, Utah: Sagebrush Press; 2001.
22. Mokrousov I, Narvskaya O, Limeschenko E, Vyazovaya A, Otten T, Vyshnevskiy B. Analysis of the allelic diversity of the mycobacterial interspersed repetitive units in Mycobacterium tuberculosis strains of the Beijing family: practical implications and evolutionary considerations. J Clin Microbiol. 2004;42:2438-2444.
23. Borgdorff MW, Van Deutekom H, De Haas PE, Kremer K, Van Soolingen D. Mycobacterium tuberculosis, Beijing genotype strains not associated with radiological presentation of pulmonary tuberculosis. Tuberculosis (Edinb). 2004;84:337-340.
24. Lopez B, Aguilar D, Orozco H, et al. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol. 2003;133:30-37.
25. Reed MB, Domenech P, Manca C, et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature. 2004;431:84-87.
26. Caminero JA, Pena MJ, Campos-Herrero MI, et al. Epidemiological evidence of the spread of a Mycobacterium tuberculosis strain of the Beijing genotype on Gran Canaria Island. Am J Respir Crit Care Med. 2001;164:1165-1170.